NASDAQ:VAXX - Nasdaq - US92244V1044 - Common Stock - Currency: USD
2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | 2019 (2019-12-31) | ||||
---|---|---|---|---|---|---|---|---|
Revenue | 0.00 | 0.00 | 70.00K | 560.00K | 0.00 | |||
Cost Of Goods | N/A | 0.00 | 1.94M | 50.00K | 0.00 | |||
Gross Profit | N/A | 0.00 | -1.87M | 510.00K | 0.00 | |||
Operating Expenses | 58.28M | 75.98M | 123.20M | 32.79M | 13.66M | |||
Research and Development | 35.90M | 47.63M | 71.38M | 20.57M | 10.66M | |||
Selling, General, and Administrative Expenses | 22.39M | 28.35M | 51.83M | 12.22M | 3.01M | |||
Operating Income | -58.28M | -75.98M | -125.08M | -32.28M | -13.66M | |||
Interest Income/Expense | 1.35M | 760.00K | -850.00K | -1.26M | -480.00K | |||
Other Income/Expense | N/A | 0.00 | -11.25M | -6.42M | -30.00K | |||
Income Before Taxes | -56.93M | -75.22M | -137.18M | -39.96M | -14.16M | |||
Income Tax | N/A | 0.00 | 0.00 | 0.00 | 60.00K | |||
Net Income | -56.93M | -75.22M | -137.18M | -39.96M | -14.22M | |||
EBITDA | -56.05M | -74.30M | -123.98M | -31.56M | -13.55M | |||
Per Share Data | ||||||||
EPS Diluted Total Ops | -0.45 | -0.60 | -1.09 | -0.32 | -0.11 | |||
Non GAAP EPS | N/A | -0.60 | N/A | N/A | N/A | |||
Statistics | ||||||||
Gross Profit Margin | N/A | N/A | -2671.43% | 91.07% | N/A | |||
Profit Margin | N/A | N/A | -195971.43% | -7135.71% | N/A | |||
Operating Profit Margin | N/A | N/A | -178685.71% | -5764.29% | N/A |
All data in USD